This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: University System of Maryland, University of Pittsburgh. Active years: 2020-2021.
Company Filing History:
2 out of 2,022 
1 out of 1,957 
Years Active: 2020-2021
Title: Eric J Sundberg: Innovator in Pharmaceutical Sciences
Introduction
Eric J Sundberg is a notable inventor based in Baltimore, MD (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that address antibiotic resistance and enhance immunotherapeutic efficacy. With a total of 2 patents, Sundberg's work is at the forefront of innovative medical solutions.
Latest Patents
One of Sundberg's latest patents focuses on the reversal of fosfomycin resistance. This patent discloses compounds, pharmaceutical compositions, and methods for reversing fosfomycin resistance. The embodiments of the disclosed compounds inhibit fosfomycin-inhibiting enzymes, with some being FosA inhibitors. The pharmaceutical compositions include fosfomycin or a pharmaceutically acceptable salt thereof, along with a compound that inhibits a fosfomycin-inhibiting enzyme. A method of inhibiting the growth of a fosfomycin-resistant bacterium involves contacting the bacterium with fosfomycin and an effective amount of a disclosed compound.
Another significant patent by Sundberg involves hyper-glycosylated antibodies with selective Fc receptor binding. This patent reveals means for improving the effector functions of current immunotherapeutic antibodies through targeted hyper-glycosylation of the antibody Fc region. The Fc receptor-mediated effector functions are critical contributors to the efficacy of numerous therapeutic antibodies currently in clinical use. Targeted hyper-glycosylation of antibodies has the potential to significantly enhance current immunotherapies for cancer.
Career Highlights
Sundberg has worked with prestigious institutions, including the University System of Maryland and the University of Pittsburgh. His research and innovations have positioned him as a key figure in the pharmaceutical industry, particularly in the areas of antibiotic resistance and cancer treatment.
Collaborations
Throughout his career, Sundberg has collaborated with notable colleagues, including Nicolas Paul Sluis-Cremer and Adam Daniel Tomich. These collaborations have further enriched his research and contributed to the advancement of his innovative projects.
Conclusion
Eric J Sundberg is a distinguished inventor whose work in pharmaceutical sciences is making a significant impact on healthcare. His patents address critical issues such as antibiotic resistance and cancer treatment, showcasing his commitment to advancing medical science.